Table 1. Signaling molecules modulating extracellular matrix dynamic changes in myocardial infarction.
Molecule | Localization | Expression Time | Effect | Refs. |
---|---|---|---|---|
Matricellular Proteins | ||||
Tenascin-C | Infarcted myocardium, border zone, remodeling myocardium | Early post-infarct period (proliferative phase of myocardial healing) | Stimulates collagen synthesis; Induces fibroblast migration and differentiation; Promotes inflammation and angiogenesis |
[102-105] |
Tenascin-X | Not known | Not known | Promotes collagen deposition; Maintains ECM preservation; Contributes to inhibition of MMP-2 and MMP-9 activity |
[106, 107] |
Trombospondin-1 | Infarct border zone | Early post-infarct period (inflammatory phase of myocardial healing) | Activates TGF-β1; Modulates fibroblast migration and differentiation; Promotes fibrogenesis; Suppresses inflammatory response; Inhibits angiogenesis; Inhibits MMPs |
[56, 121, 122] |
Trombospondin-2 | Not known | Late post-infarct period after trombospondin-1 level decreases | Exerts anti-inflammatory effects; Reduces angiogenesis; Inhibits MMPs; Modulates fibroblast interactions with fibronectin |
[121, 123, 124] |
Osteonectin | Infarcted myocardium, non-infarcted myocardium | Early and late post-infarct period (3rd - 14th day) | Modulates activity of TGF-β, fibroblasts growth factor, platelets growth factor, vascular endothelial growth factor; Induces myocardial cells de-adhesion; Promotes angiogenesis; Regulates assembly of newly-formed collagen |
[108-111] |
Osteopontin | Infarcted myocardium, non-infarcted myocardium |
Early and late post-infarct period (1st - 28th day) | Induces collagen synthesis and organization; Inhibits cell apoptosis; Modulates growth factor signaling; Activates angiogenesis |
[114-119] |
Periostin | Infarcted myocardium, border zone, remodeling myocardium | Early and late post-infarct period (3rd - 28th day) | Promotes fibroblasts migration and differentiation; Stimulates fibrillogenesis |
[125-128] |
CCN-2 | Infarcted myocardium | Early and late post-infarct period (7th-28th day) | Activates TGF-β1 signaling pathways; Stimulates angiogenesis; Promotes fibroblast migration and differentiation; Exerts cardioprotective effect |
[130-133] |
Proteins with matricellular function | ||||
Biglycan | Infarcted myocardium, border zone | Early and late post-infarct period (2nd – 28th day) with peaking at 14th day | Stimulates collagen deposition and appropriate cross-linking; Regulates fibroblast phenotype and function; Decreases ventricular dilation; Attenuates ventricular rupture; Modulates scar organization |
[100, 135] |
Decorin | Infarcted myocardium, border zone | Early and late post-infarct period (7th-28thday) with peaking at 14th day | Regulates collagen fibrillogenesis and proper matrix assembly; Decreases infarct size and ventricular hypertrophy; Diminishes left ventricular dilation; Promotes scar organization |
[100, 134] |
Molecule | Localization | Expression Time | Effect | Refs. |
Syndecans | Infarcted myocardium | Early post-infarct period (24h – 7th day peak) | Prevent excessive matrix degradation; Enhance myofibroblast transdifferentiation; Stimulate growth factor-dependent endothelial cell proliferation; Promote angiogenesis; Reduce myocardial inflammation and fibrosis; Inhibit cardiomyocyte apoptosis |
[138, 139] |
Galectins | Infarcted myocardium | Early post-infarct period (2nd -14th day) | Induce fibroblast proliferation; Promote matrix deposition; Stimulate macrophage migration |
[136, 137] |
Growth factors | ||||
Transforming growth factor beta | Predominantly infarct border zone | Early and late post-infarct period (3rd - 28th day) | Promotes myofibroblast differentiation; Increases collagen and fibronectin synthesis; Activates TIMP; Stimulates cardiomyocyte hypertrophy; Induces mononuclear cells chemotaxis; Promotes angiogenesis; Reduces oxidative stress; Protects cardiomyocytes from apoptosis |
[54, 56, 120] |
Fibroblast growth factor | Infarcted myocardium, border zone | Early and late post-infarct period (7th-28th day) | Promotes proliferation of fibroblasts, endothelial cells, smooth muscle cells; Regulatesprocesses of cell survival, migration, differentiation and apoptosis; Stimulates angiogenesis; Attenuates fibroblast proliferation and collagen deposition |
[59, 60] |
Platelet derived growth factor | Infarcted myocardium | Early and late post-infarct period (7th-28th day) | Regulates fibroblast migration, proliferation and transformation; Promotes fibrogenesis; Induces TGF-β synthesis; Facilitates stabilization and maturation of neovessels; Promotes resolution of inflammation |
[53, 62] |
Vascular endothelial growth factor | Infarcted myocardium, border zone | Early and late post-infarct period (24 hours – 6 weeks) | Promotes angiogenesis and proliferation of endothelial cells; Inhibits cardiomyocyte apoptosis; Enhances myocardial contractility |
[63, 64] |
Cardiotrophin-1 | Predominantly infarcted myocardium | Early and late pot-infarct period (24 hours – 8 weeks) | Induces cardiomyocyte survival; Inhibits cardiomyocyte apoptosis; Attenuates ischemia/reperfusion myocardium injury; Maintains myocardial contractility by stimulation of cardiomyocyte hypertrophy; Stimulates fibroblast migration and proliferation; Induces bone marrow stem cells migration; Stimulates synthesis of multiple extracellular matrix proteins |
[65, 80, 81] |